Clinical Trial: Steroids in Fulminant Hepatic Failure in the Pediatric Age Group

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: Safety and Efficacy of Steroids in the Management of Fulminant Hepatic Failure in the Pediatric Age Group

Brief Summary: Fulminant hepatic failure (FHF) in children is a potentially devastating disease. The mortality rate may reach 80-90% in the absence of liver transplantation. Liver injury is considered to be mainly immune mediated with augmentation of cytolytic pathways of infected hepatocytes. For that, it is suggested that corticosteroids modulate the activity of the disease by suppressing the immune system.